FDA Drug Recalls

Recalls / Class II

Class IID-1495-2020

Product

Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx only, SCA Pharmaceuticals 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0650-46

Affected lot / code info
Lot #: 1220018755, Exp. Date 7/30/2020; 1220018861, 1220018850, Exp. Date 8/4/2020; 1220018899, Exp. Date 8/5/2020; 1220019027, Exp. Date 8/11/2020; 1220019075, Exp. Date 8/12/2020; 1220019243, Exp. Date 8/20/2020; 1220019439, 1220019279, 1220019392, Exp. Date 8/24/2020; 1220019488, Exp. Date 8/26/2020

Why it was recalled

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Recalling firm

Firm
SCA Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, N/A, Windsor, Connecticut 06095-1024

Distribution

Quantity
3,932 bags
Distribution pattern
Product was distributed nationwide within the United States.

Timeline

Recall initiated
2020-07-29
FDA classified
2020-08-12
Posted by FDA
2020-08-19
Terminated
2021-03-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1495-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.